OTC · Financial Statements
GeneLink, Inc. (GNLKQ) Financial Statements
$0.00
OTC: GNLKQ
Market Cap $10601
Overview Financials Dividend GeneLink, Inc. most recently reported annual revenue of $2.0M, a net loss of $3.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2008 2009 2010 2011 2012 Revenue $6.0M $9.0M $8.0M $5.0M $2.0M Operating Profit $-2.0M $-2.0M $-2.0M $-4.0M $-3.0M Net Profit $-3.0M $-3.0M $-3.0M $-4.0M $-3.0M EPS $-0.03 $-0.03 $-0.02 $-0.02 $-0.01 Op Margin -35.0% -28.8% -30.6% -76.1% -162.4%
Balance Sheet (USD)
Metric 2008 2009 2010 2011 2012 Total Assets $3.0M $2.0M $2.0M $3.0M $1.0M Total Liabilities $2.0M $3.0M $3.0M $4.0M $4.0M Cash $0 $0 $0 $1.0M $0 Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2008 2009 2010 2011 2012 Operating Cash Flow $-1.0M $-3.0M $-1.0M $-3.0M $-2.0M Investing Cash Flow $-1.0M $0 $0 $0 $0 Financing Cash Flow $1.0M $1.0M $0 $1.0M $0 Net Cash Flow $-1.0M $0 $0 $0 $-1.0M Free Cash Flow $-2.0M $-3.0M $-1.0M $-3.0M $-3.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.06 FCF Yield -24767.22% Quick Ratio 0.21 Interest Coverage -10.48 Return 1Y 0.00% Return 3Y -60.00% Return 5Y —
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer .